Methodist Richardson Medical Center
Richardson, Texas, 75082, United States
Location status: Recruiting
Location contact
Crystee Cooper, DHEd
CONTACT
Dhiresh Jeyarajah, MD
PRINCIPAL_INVESTIGATOR
Zaid Haddadin, MS
CONTACT
NCT Number: NCT06343597
This is a retrospective analysis to assess if high-volume hospital facilities experience greater or lesser rates of incidence in patients with esophageal cancer than low-volume facilities.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Richardson, Texas, 75082, United States
Location status: Recruiting
Crystee Cooper, DHEd
CONTACT
Dhiresh Jeyarajah, MD
PRINCIPAL_INVESTIGATOR
Zaid Haddadin, MS
CONTACT
This is a retrospective analysis to assess if high-volume hospital facilities experience greater or lesser rates of incidence in patients with esophageal cancer than low-volume facilities.
The relationship between volume and outcomes has been proven in pancreatic cancer. Similar to pancreatic cancer, esophageal cancer historically has a bad prognosis. Esophageal cancer is typically asymptomatic, resulting in an advanced stage at the time of diagnosis. Additionally, it also has a significantly high morbidity and mortality. Therefore, it is crucial to determine volume-outcome relationships in esophageal cancer. This study aims to elucidate what these findings may entail by evaluating the impact that the volume-outcome relationship has on treatment assessment in esophageal cancer patients.
The purpose of the study is to evaluate the outcomes of esophageal cancer resection in patients in high volume (more than 5 esophagectomy performed per year) and low volume (less than 5 esophagectomy performed per year) hospital facilities. Furthermore, this paper will assess the outcomes of neoadjuvant and adjuvant therapy in esophageal cancer.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: through study completion, up to 18 months
Retrospective analysis to assess if high-volume hospital facilities experience greater or lesser rates of incidence in patients with Esophageal Cancer than low-volume facilities
Contact information is provided by the study sponsor or research team.
Crystee Cooper, DHEd
CONTACT
Zaid Haddadin, MS
CONTACT
Methodist Health System
Other
Volume Outcome Relationships and Effects of Adjuvant and Neoadjuvant Therapy in Mortality in Esophageal Cancer
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06906887
Digestive System Diseases, Digestive System Neoplasms
Milwaukee, Wisconsin, United States
View Trial DetailsNCT06465069
Adnexal Diseases, Advanced Solid Tumor
Duarte, California, United States
View Trial DetailsNCT06445972
Digestive System Diseases, Digestive System Neoplasms
Tucson, Arizona, United States
View Trial DetailsNCT06910657
Adenocarcinoma, Adnexal Diseases
St Louis, Missouri, United States
View Trial Details